Showing 1 - 5 results of 5 for search 'Anna Säll', query time: 0.03s Refine Results
  1. 1
    Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range.

    Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range. by Anna Säll, Daniel Corbee, Sara Vikström, Filip Ottosson, Helena Persson, Sofia Waldemarson

    Published 2018-01-01
    Get full text
    Article
  2. 2
    RUBY® – a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties

    RUBY® – a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties by Barnabas Nyesiga, Mattias Levin, Anna Säll, Anna Rosén, Kim Jansson, Sara Fritzell, Karin Hägerbrand, Dietmar Weilguny, Laura von Schantz

    Published 2024-12-01
    Get full text
    Article
  3. 3
    858 A bispecific antibody targeting CD40 and EpCAM induces superior anti-tumor effects compared to the combination of the monospecific antibodies

    858 A bispecific antibody targeting CD40 and EpCAM induces superior anti-tumor effects compared to the combination of the monospecific antibodies by Peter Ellmark, Karin Hägerbrand, Doreen Werchau, Anna Rosén, Karin Barchan, Adnan Deronic, Mattias Levin, Laura Von Schantz, Laura Varas, Anna Säll, Lill Ljug, Mia Thageson, Christina Sakellariou

    Published 2020-11-01
    Article
  4. 4
    751 Neo-X-Prime bispecific antibodies targeting CD40 and tumor antigens promote cross-presentation of tumor exosome-derived neoantigen and induce superior anti-tumor responses compared to CD40 mAb

    751 Neo-X-Prime bispecific antibodies targeting CD40 and tumor antigens promote cross-presentation of tumor exosome-derived neoantigen and induce superior anti-tumor responses comp... by Peter Ellmark, Karin Hägerbrand, Mia Thagesson, Doreen Werchau, Anna Rosén, Karin Barchan, Anette Sundstedt, Adnan Deronic, Lill Ljung, Mattias Levin, Laura Von Schantz, Laura Varas, Anna Säll, Barnabas Nyesiga, Eva Lindqvist

    Published 2021-11-01
    Article
  5. 5
    Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies

    Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies by Malin Lindstedt, Peter Ellmark, Lennart Greiff, Karin Hägerbrand, Laura von Schantz, Mia Thagesson, Doreen Werchau, Kristine Smedenfors, Anna Rosén, Anette Sundstedt, Adnan Deronic, Lill Ljung, Mattias Levin, Laura Varas, Anna Säll, Christina Sakellariou, Barnabas Nyesiga, David Gomez Jimenez, Mona Celander, Deniz Bölükbas, Fredrika Carlsson

    Published 2022-11-01
    Get full text
    Article

Search Tools: